Finance

Lists
DHR:NYSE
Danaher Corp
၂၂၄.၆၉ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၄, GMT-၄ ၁၆:၀၄:၀၉  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DHR...
Mkt. cap
ဋေ ၁.၅၈ သ
Avg. vol.
၄.၂၀ သန်း
Volume
၂.၃၁ ထောင်
Dividend
၀.၇၁%
Quarterly dividend
၀.၄၀ US$
Ex-dividend date
၂၀၂၆ စက် ၃၀
P/E ratio
၃၉.၈၉
52-wk high
၂၄၂.၈၀ US$
52-wk low
၁၆၀.၉၃ US$
EPS
၅.၆၃ US$
Beta
၀.၇၇
Shares outstanding
၇၀.၃၀ ကုဋေ
No. of employees
၆ သောင်း
Mkt. cap
ဋေ ၁.၅၈ သ
Avg. vol.
၄.၂၀ သန်း
Volume
၂.၃၁ ထောင်
Dividend
၀.၇၁%
Quarterly dividend
၀.၄၀ US$
Ex-dividend date
၂၀၂၆ စက် ၃၀
P/E ratio
၃၉.၈၉
52-wk high
၂၄၂.၈၀ US$
52-wk low
၁၆၀.၉၃ US$
EPS
၅.၆၃ US$
Beta
၀.၇၇
Shares outstanding
၇၀.၃၀ ကုဋေ
No. of employees
၆ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၄ နာရီ
Danaher partners with NVIDIA and Danaher stock costs EUR 202.55 on October 15, 2026 best-effort
NAI500
NAI500
·
ပြီးခဲ့သည့် ၁၀ နာရီ
Will Third-Quarter Earnings Be the Turning Point for These Two Lagging Healthcare Stocks?
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၁၆ နာရီ
For no consideration, Danaher (DHR) chairman waives his stock award.
Zacks
Zacks
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp
CEORainer M. Blair
Employees၅.၉ သောင်း
Founded၁၉၆၉
Headquarters-
Sector-
Analyst ratings
Based on 17 analysts giving stock ratings to DHR in the past 3 months
Strong buy
Buy
16
Hold
1
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for DHR in the last 3 months.
Highest
Current ၂၂၄.၆၉ US$
၂၅၅.၀၀ US$ (+၁၃.၄၉%)
Average
၂၃၅.၃၁ US$ (+၄.၇၃%)
Lowest
၂၀၀.၀၀ US$ (-၁၀.၉၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Brennan
TD Cowen
Buy
Maintained
၂၅၅.၀၀ US$
+၁၃.၅%
10/13/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Reiterated
၂၄၀.၀၀ US$
+၆.၈%
10/13/2026
Lu Li
Bank of America Securities
Buy
Maintained
၂၅၅.၀၀ US$
+၁၃.၅%
10/09/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
၂၅၅.၀၀ US$
+၁၃.၅%
10/09/2026
Luke Sergott
Barclays
Buy
Maintained
၂၅၅.၀၀ US$
+၁၃.၅%
10/07/2026
Evie Koslosky
Goldman Sachs
Buy
Maintained
၂၅၀.၀၀ US$
+၁၁.၃%
10/05/2026
Dan Leonard
RBC Capital
Buy
Maintained
၂၅၀.၀၀ US$
+၁၁.၃%
10/04/2026
Subbu Nambi
Guggenheim
Buy
Maintained
၂၅၀.၀၀ US$
+၁၁.၃%
10/01/2026
Joanne Wuensch
Citi
Buy
Maintained
၂၃၀.၀၀ US$
+၂.၄%
09/21/2026
Tycho Peterson
Jefferies
Buy
Maintained
၂၁၀.၀၀ US$
-၆.၅%
09/18/2026
Doug Schenkel
UBS
Buy
Initiated
၂၅၀.၀၀ US$
+၁၁.၃%
09/13/2026
David Westenberg
Piper Sandler
Hold
Maintained
၂၀၀.၀၀ US$
-၁၁%
07/27/2026
David Toung
Argus Research
Buy
Reiterated
၂၃၀.၀၀ US$
+၂.၄%
07/23/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
၂၂၀.၀၀ US$
-၂.၁%
07/23/2026
Justin Bowers
Deutsche Bank
Buy
Reiterated
၂၄၀.၀၀ US$
+၆.၈%
07/22/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/22/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
၂၂၀.၀၀ US$
-၂.၁%
07/22/2026
Patrick B Donnelly
Citi
Buy
Maintained
၂၃၀.၀၀ US$
+၂.၄%
07/22/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
၁၉၅.၀၀ US$
-၁၃.၂%
07/22/2026
Aristotelis Moutopoulos
DZ BANK AG
Buy
Maintained
၂၁၀.၀၀ US$
-၆.၅%
07/22/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
၂၃၀.၀၀ US$
+၂.၄%
07/06/2026
Unknown Analyst
DZ BANK AG
Buy
Initiated
၂၁၀.၀၀ US$
-၆.၅%
06/03/2026
Sidharth Sahoo
HSBC
Buy
Maintained
၂၃၀.၀၀ US$
+၂.၄%
06/03/2026
Michael Polark
Wolfe Research
Hold
Downgraded
-
-
06/01/2026
Unknown Analyst
RBC Capital
Buy
Initiated
၂၀၀.၀၀ US$
-၁၁%
05/14/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
၂၄၅.၀၀ US$
+၉%
04/22/2026
Ed Ridley-Day
Rothschild & Co Redburn
Hold
Maintained
၂၀၅.၀၀ US$
-၈.၈%
04/17/2026
Unknown Analyst
Goldman Sachs
Buy
Reiterated
၂၃၀.၀၀ US$
+၂.၄%
04/14/2026
Next call ၆ ရက်အတွင်း
အောက် ၂၁ ဗုဒ္ဓဟူး, ၁၄:၀၀
Fiscal period
Q3 2026
- / ၁.၉၂ US$
Revenue / Est. (USD)
- / ၆၅၅.၉၇ ဋေ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၆၀၅.၃၀ ဋေ
၆၈၃.၈၀ ဋေ
၅၉၅.၁၀ ဋေ
၆၂၆.၅၀ ဋေ
Cost of goods sold
၂၅၃.၀၀ ဋေ
၂၈၅.၈၀ ဋေ
၂၃၆.၀၀ ဋေ
၂၆၀.၈၀ ဋေ
Cost of revenue
၂၅၃.၀၀ ဋေ
၂၈၅.၈၀ ဋေ
၂၃၆.၀၀ ဋေ
၂၆၀.၈၀ ဋေ
Research and development expenses
၃၇.၈၀ ကုဋေ
၄၃.၈၀ ကုဋေ
၃၈.၇၀ ကုဋေ
၄၁.၂၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၈၈.၉၀ ဋေ
၂၀၂.၆၀ ဋေ
၁၈၃.၉၀ ဋေ
၂၀၀.၆၀ ဋေ
Operating expense
၂၂၆.၇၀ ဋေ
၂၄၆.၄၀ ဋေ
၂၂၂.၆၀ ဋေ
၂၄၁.၈၀ ဋေ
Total operating expenses
၄၇၉.၇၀ ဋေ
၅၃၂.၂၀ ဋေ
၄၅၈.၆၀ ဋေ
၅၀၂.၆၀ ဋေ
Operating income
၁၂၅.၆၀ ဋေ
၁၅၁.၆၀ ဋေ
၁၃၆.၅၀ ဋေ
၁၂၃.၉၀ ဋေ
Other non operating income
-
-၈.၇၀ ကုဋေ
-
-
EBT including unusual items
၁၀၇.၆၀ ဋေ
၁၃၇.၃၀ ဋေ
၁၂၃.၅၀ ဋေ
၁၀၇.၈၀ ဋေ
EBT excluding unusual items
၁၁၉.၂၀ ဋေ
၁၃၈.၇၀ ဋေ
၁၃၂.၉၀ ဋေ
၁၁၉.၃၀ ဋေ
Income tax expense
၁၆.၈၀ ကုဋေ
၁၉.၀၀ ကုဋေ
၂၀.၆၀ ကုဋေ
၂၀.၈၀ ကုဋေ
Effective tax rate
၁၅.၆၁%
၁၃.၈၄%
၁၆.၆၈%
၁၉.၂၉%
Other operating expenses
-
-
-
-
Net income
၉၀.၈၀ ကုဋေ
၁၁၉.၇၀ ဋေ
၁၀၂.၉၀ ဋေ
၈၇.၀၀ ကုဋေ
Net profit margin
၁၅.၀၀%
၁၇.၅၁%
၁၇.၂၉%
၁၃.၈၉%
Earnings per share
၁.၈၉
၂.၂၃
၂.၀၆
၁.၉၄
Interest and investment income
၃.၀၀ သန်း
၁.၃၀ ကုဋေ
၂.၇၀ ကုဋေ
၆.၁၀ ကုဋေ
Interest expense
-၆.၇၀ ကုဋေ
-၅.၅၀ ကုဋေ
-၆.၃၀ ကုဋေ
-၁၀.၇၀ ကုဋေ
Net interest expenses
-၆.၄၀ ကုဋေ
-၄.၂၀ ကုဋေ
-၃.၆၀ ကုဋေ
-၄.၆၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၈၇.၈၀ ဋေ
၂၁၃.၉၀ ဋေ
၁၉၉.၂၀ ဋေ
၁၈၉.၈၀ ဋေ
Gain or loss from assets sale
-၉.၀၀ သန်း
၉.၀၀ သန်း
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ